Every day, the MarketScreener team selects the most important news about public companies from around the world. For your reference, I will briefly summarize it.
- Nokia has lowered its profit margin target for 2026.
- Oracle fell 8.8% in after-hours trading after disappointing results.
- AstraZeneca will acquire Icosavax for $15 per share ($1.1 billion) plus contingent consideration.
- NVIDIA and the US are in talks about licensing and selling artificial intelligence chips to Chinese companies.
- The UK competition watchdog is investigating Unilever’s environmental claims for certain products.
- KKR will negotiate to acquire 50% of Cotiviti from Veritas Capital.
- Hasbro plans to cut 1,100 jobs, according to WSJ.
- Eli Lilly published a study showing that patients taking tirzepatide (Zepbound/Mounjaro) regained weight when switched to a placebo.
- Shell is selling its interests in two US renewable energy projects.
- Google lost a lawsuit against Epic Games over its app store.
- Li Ning agreed to buy back up to HK$3 billion worth of company shares after the stock price fell.
- Bristol-Myers Squibb will pay $800 million upfront to its Sichuan Biokin unit to develop and market one of its cancer drugs outside China.
- According to Reuters, Boeing plans to cut more staff than its strategic staff had predicted.
- Banco BPM will return €4 billion to investors as part of a new plan.
- Nokia plans to move its U.S. research and development center in New Jersey from Murray Hill to New Brunswick by 2028.
- Schein is reportedly in talks for a possible London listing, but New York is on hold.
- Alphabet is down 1.1% in pre-market trading after losing a lawsuit against video game publisher Epic Games, the developer of Fortnite, accusing it of illegally monopolizing online app store Google Play. It fell.
- Oracle fell 8.13% in pre-market trading after the company released a lower-than-expected quarterly revenue forecast, citing economic uncertainty and competition in the cloud computing market.
- JPMorgan Chase & Co. plans to outsource its custody operations in Hong Kong and Taiwan, where Citigroup, HSBC and Standard Chartered are vying for the job, two people familiar with the matter said.
- Pfizer on Tuesday said it has agreed to waive royalties from sales of the cancer drug Bavencio to address concerns raised by U.S. antitrust regulators in connection with its $43 billion acquisition of Seagen. did.
- Bristol-Myers Squibb Co. said Monday it will pay Sichuan Biokin Pharmaceuticals $800 million, or up to $8.4 billion, to develop and sell one of the Chinese manufacturer’s cancer drugs outside of China.
- Icosavax soared 45% before trading after AstraZeneca announced it was acquiring the company for $1.1 billion.
- Lucid – The luxury electric vehicle maker fell 4.6% pre-market after announcing the resignation of Chief Financial Officer Shelley House.
- Metaplatform – Turkey’s competition regulator announced on Tuesday that it had opened an investigation into the group, which linked threads to the Instagram social media platform.
- FirstEnergy – Activist investor Carl Icahn has been forced to reduce his stake in the group by 1.5% and relinquish his seat on the board.
![Image Romain Fournier](https://zonebourse.com/images/author/equipeZB_G74.jpg)